Minimally oxidized LDL is a potent inhibitor of lecithin:cholesterol acyltransferase activity

Journal of Lipid Research

Volumn 37, Issue 5, 1996, Pages 1012-1021

  Bielicki, John K ^a   Forte, Trudy M ^a   McCall, Mark R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Crosslinking of apoA I; Early atherogenesis; Inhibition of LCAT activity; Lipid peroxidation; Reverse cholesterol transport

Indexed keywords

ACYLTRANSFERASE INHIBITOR; APOLIPOPROTEIN A1; CHOLESTEROL ESTER; COPPER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPID OXIDATION; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROTEOLIPOSOME;

APOLIPOPROTEIN A-I; CHEMICAL FRACTIONATION; COPPER; CROSS-LINKING REAGENTS; ENZYME INHIBITORS; EVALUATION STUDIES; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 0029943661     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am. J. Med. 62: 707-714.
2. Rifkind, B. M. 1990. High density lipoprotein cholesterol and coronary artery disease: survey of the evidence. Am. J. Cardiol. 66: 3A-6A.
3. Wilson, P. W. F. 1990. High density lipoprotein, low density lipoprotein and coronary artery disease. Am. J. Cardiol. 66: 7A-10A.
4. Glomset, J. A. 1968. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167.
5. Tall, A. R. 1990. Plasma high density lipoproteins: metabolism and relationship to atherogenesis. J. Clin. Invest. 86: 379-384.
6. Rothblat, G. H., and M. C. Phillips. 1991. Cholesterol efflux from arterial wall cells. Curr. Opin. Lipidol. 2: 288-294.
7. Johnson, W. J., F. H. Mahlberg, G. K. Chacko, M. C. Phillips, and G. H. Rothblat. 1988. The influence of cellular and lipoprotein cholesterol contents on the flux of cholesterol between fibroblasts and high density lipoprotein. J. Biol. Chem. 263: 14099-14106.
8. Aron, L., S.Jones, and C.J. Fielding. 1978. Human plasma lecithin-cholesterol acyltransferase: characterization of cofactor-dependent phospholipase activity. J. Biol. Chem. 253: 7220-7226.
9. Jonas, A. 1991. Lecithin-cholesterol acyltransferase in the metabolism of high density lipoproteins. Biochim. Biophys. Acta. 1084: 205-220.
10. Ohta, T., R. Nakamura, Y. Ikeda, M. Shinohara, A. Miyazaki, S. Horiuchi, and I. Matsuda. 1992. Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin:cholesterol acyltransferase. Biochim. Biophys. Acta. 1165: 119-128.
11. Vaisman, B. L., H-G. Klein, M. Rouis, A. M. Bérard, M. R. Kindt, G. D. Talley, S. M. Meyn, R. F. Hoyt, S. M. Marcovina, J. J. Albers, J. M. Hoeg, H. B. Brewer, and S. Santamarina-Fojo. 1995. Overexpression of human leciihin:cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J. Biol. Chem. 270: 12269-12275.
12. Quinn, M. T., S. Parthasarathy, L. G. Fong, and D. Steinberg. 1987. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA. 84: 2995-2998.
13. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol: modification of low density lipoprotein that increases its atherogenicity. N. Engl. J. Med. 320: 915-924.
14. Berliner, J. A., M. C. Territo, A. Sevanian, S. Ramin, J. A. Kim, B. Bamshad, M. Esterson, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85: 1260-1266.
15. Hodis, H. N., D. M. Kramsch, P. Avogaro, G. Bittolo-Bon, G. Cazzolato, J. Hwang, H. Peterson, and A. Sevanian. 1994. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J. Lipid Res. 35: 669-677.
16. Hessler, J. R., D. W. Morel, L. J. Lewis, and G. M. Chisolm. 1983. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 3: 215-222.
17. Kosugi, K., D. W. Morel, P. E. DiCorleto, and G. M. Chisolm. 1987. Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle. J. Cell. Physiol. 130: 311-320.
18. Schmitt, A., A. Nègre-Salvayre, M. Troly, P. Valdiguié, and R. Salvayre. 1995. Phospholipid hydrolysis of mildly oxidized LDL reduces their cytotoxicity to cultured endothelial cells: potential protective role against atherogenesis. Biochim. Biophys. Acta. 1256: 284-292.
19. Palinski, W., M. E. Rosenfeld, S. Ylä-Herttuala, G. C. Gurtner, S. S. Socher, S. W. Butler, S. Parthasarathy, T. E. Carew, D. Steinberg, and J. L. Witztum. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86: 1372-1376.
20. Rosenfeld, M. E., J. C. Khoo, E. Miller, S. Parthasarathy, W. Palinski, and J. L. Witztum. 1991. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low density lipoproteins, and contain oxidation-specific lipid-protein adducts. J. Clin. Invest. 87: 90-99.
21. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76: 333-337.
22. Mahley, R. W., T. L. Innerarity, K. H. Weisgraber, and S. Y. Oh. 1979. Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. J. Clin. Invest. 64: 743-750.
23. Henriksen, T., E. M. Mahoney, and D. Steinberg. 1981. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoprotein. Proc. Natl. Acad. Sci. USA. 78: 6499-6503.
24. Parthasarathy, S., J. Barnett, and L. G. Fong. 1990. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta. 1044: 275-283.
25. Watson, A. D., M. Navab, S. Y. Hama, A. Sevanian, S. M. Precott, D. M. Stafforini, T. M. McIntyre, B. N. La Du, A. M. Fogelman, and J. A. Berliner. 1995. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95: 774-782.
26. Matsuda, Y., K. Hirata, N. Inoue, M. Suematsu, S. Kawashima, H. Akita, and M. Yokoyama. 1993. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ. Res. 72: 1103-1109.
27. Bowry, V. W., K. K. Stanley, and R. Stocker. 1992. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. USA. 89: 10316-10320.
28. Bielicki, J. K., M. R. McCall, J. J. M. van den Berg, F. A. Kuypers, and T. M. Forte. 1995. Copper and gas-phase cigarette smoke inhibit plasma lecithin:cholesterol acyltransferase activity by different mechanisms. J. Lipid Res. 36: 322-331.
29. McCall, M. R., J. Y. Tang, J. K. Bielicki, and T. M. Forte. 1995. Inhibition of lecithin:cholesterol acyltransferase and modification of HDL-apolipoproteins by aldehydes. Arterioscler. Thromb. Vasc. Biol. 15: 1599-1606.
30. Lindgren, F. T., L. C. Jensen, and F. T. Hatch. 1972. The isolation and quantitative analysis of serum lipoproteins. In Bloods, Lipids, and Lipoproteins: Quantitation, Composition, and Metabolism. G. J. Nelson, editor. Wiley-Interscience, New York. 181-274.
31. Kosugi, H., T. Kojima, and K. Kikugawa. 1991. Characteristics of the thiobarbituric acid reactivity of oxidized fats and oils. J. Am. Oil Chem. Soc. 68: 51-55.
32. Markwell, M. K., S. M. Haas, L. L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210.
33. Nichols, A. V., R. M. Krauss, and T. A. Musliner. 1986. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 128: 417-431.
34. Chen, C., and J. J. Albers. 1982. Characterization of proteoliposomes containing apoproteinA-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase activity. J. Lipid Res. 23: 680-691.
35. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. 37: 911-917.
36. Bamberger, M., S. Lund-Katz, M. C. Phillips, and G. H. Rothblat. 1985. Mechanism of the hepatic lipase-induced accumulation of high-density lipoprotein cholesterol by cells in culture. Biochemistry. 24: 3693-3701.
37. Francone, O. L., and C. J. Fielding. 1991. Effects of site-directed mutagenesis at residues cysteine-31 and cysteine184 on lecithin-cholesterol acyltransferase activity. Proc. Natl. Acad. Sci. USA. 88: 1716-1720.
38. Francone, O. L., and C. J. Fielding. 1991. Structure-function relationships in human lecithin-cholesterol acyltransferase. Site-directed mutagenesis at serine residues 181-216. Biochemistry. 30: 10074-10077.
39. Tanaka, M., and S. Kanamaru. 1993. Capillary gas chromatography quantification of cholesterol in copper-oxidized low-density lipoprotein. Biol. Pharm. Bull. 16: 538-543.
40. Szedlacsek, S. E., E. Wasowicz, S. A. Hulea, H. I. Nishida, F. A. Kummerow, and T. Nishida. 1995. Esterification of oxysterols by human lecithin-cholesterol acyltransferase. J. Biol. Chem. 270: 11812-11819.
41. Nagano, Y., H. Arai, and T. Kita. 1991. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc. Natl. Acad. Sci. USA. 88: 6457-6461.
42. Maziere, J. C., I. Myara, S. Salmon, M. Auclair, J. Haigle, R. Santus, and C. Maziere. 1993. Copper- and malondialdehyde-induced modification of high density lipoprotein and parallel loss of lecithin:cholesterol acyltransferase activation. Atherosclerosis. 104: 213-219.
43. 3 in rat. Biochim. Biophys. Acta. 1046: 81-88.
44. Lui, R., K. Saku, B. Zhang, K. Hirata, M. Shiomi, and K. Arakawa. 1993. In vivo kinetics of oxidatively modified HDL. Biochem. Med. & Metab. Biol. 49: 392-397.
45. Avogaro, P., G. Bittolo Bon, and G. Cazzolato. 1988. Presence of modified low density lipoprotein in humans. Arteriosclerosis. 8: 79-87.
46. Haberland, M. E., D. Fong, and L. Cheng. 1988. Malondialdehyde-altered protein occurs in atheroma of watanabe heritable hyperlipidemic rabbits. Science. 241: 215-218.
47. Williams, K. J., and I. Tabas. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15: 551-560.
48. Nordestgaard, B. G., and L. B. Nielson. 1994. Atherosclerosis and arterial influx of lipoproteins. Curr. Opin. Lipidol. 5: 252-257.
49. Navab, M., S. S. Imes, S. Y. Hama, G. P. Hough, L. A. Ross, R. W. Bork, A. J. Valente, J. A. Berliner, D. C. Drinkwater, H. Laks, and A. M. Fogelman. 1991. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J. Clin. Invest. 88: 2039-2046.
50. Cushing, S. D., J. A. Berliner, A. J. Valente, M. C. Territo, M. Navab, F. Parhami, R. Gerrity, C. J. Schwartz, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87: 5134-5138.
51. Liao, F., J. A. Berliner, M. Mehrabian, M. Navab, L. L. Demer, A. J. Lusis, and A. M. Fogelman. 1991. Minimally modified low density lipoprotein is biologically active in vivo in mice. J. Clin. Invest. 87: 2253-2257.
52. Frostegard, J., A. Haegerstrand, M. Gidlund, and J. Nilsson. 1991. Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis. 90: 119-126.
53. Steinbrecher, U. P., S. Parthasarathy, D. S. Leake, J. L. Witztum, and D. Steinberg. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81: 3883-3887.
54. Shen, B. W., A. M. Scanu, and F. J. Kezdy. 1977. Structure of human serum lipoproteins inferred from compositional analysis. Proc. Natl. Acad. Sci. USA. 74: 837-841.